Halyard Health, Inc. to Present at JMP Securities Life Sciences Conference
Get Alerts HYH Hot Sheet
Join SI Premium – FREE
ALPHARETTA, Ga., June 23, 2015 /PRNewswire/ -- Halyard Health, Inc. (NYSE: HYH) today announced that Steve Voskuil, chief financial officer, will present at the 2015 JMP Securities Life Sciences Conference in New York at approximately 10:00 a.m., EDT on Wednesday, June 24.
A webcast of the conference presentation will be available in the Investors section of the Halyard Health website at https://halyardhealth.investorroom.com/ and will be archived on that site.
About Halyard Health: Halyard Health (NYSE: HYH) is a medical technology company focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. Headquartered in Alpharetta, Georgia, Halyard is committed to addressing some of today's most important healthcare needs, such as preventing healthcare-associated infections and reducing the use of narcotics while helping patients move from surgery to recovery. Halyard's business segments — Surgical and Infection Prevention and Medical Devices — develop, manufacture and market clinically superior solutions that improve medical outcomes and business performance in more than 100 countries. For more information, visit www.halyardhealth.com.
Logo - http://photos.prnewswire.com/prnh/20141031/155877LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/halyard-health-inc-to-present-at-jmp-securities-life-sciences-conference-300102704.html
SOURCE Halyard Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Semtech Announces Second Quarter of Fiscal Year 2027 Results
- AEO Inc. to Report Second Quarter Fiscal 2026 Results on September 9, 2026
- Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share